Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
232.03
-3.40 (-1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corp
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
$1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today
August 23, 2022
Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of...
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22
August 22, 2022
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report
Via
Benzinga
FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children
August 22, 2022
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with...
Via
Benzinga
FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above
August 22, 2022
Via
Benzinga
What 8 Analyst Ratings Have To Say About Insulet
August 05, 2022
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:
Via
Benzinga
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
August 05, 2022
Via
Benzinga
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
August 22, 2022
From
Insulet Corporation
Via
Business Wire
Insulet to Present at Upcoming Investor Conferences
August 05, 2022
From
Insulet Corporation
Via
Business Wire
Recap: Insulet Q2 Earnings
August 04, 2022
Insulet (NASDAQ:PODD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Insulet missed estimated earnings by...
Via
Benzinga
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)
August 04, 2022
From
Insulet Corporation
Via
Business Wire
5 Analysts Have This to Say About Insulet
June 24, 2022
Insulet (NASDAQ:PODD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
4 Analysts Have This to Say About Insulet
June 07, 2022
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:
Via
Benzinga
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
August 01, 2022
From
Insulet Corporation
Via
Business Wire
The Healthcare Companies Fighting the World’s Biggest Killers
July 13, 2022
Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the...
Via
FinancialNewsMedia
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
June 30, 2022
From
Insulet Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
July 11, 2022
Upgrades
Via
Benzinga
7 Stocks to Buy That Could Make You a Millionaire
June 23, 2022
These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments.
Via
InvestorPlace
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close
June 16, 2022
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness...
Via
Benzinga
Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years
June 03, 2022
From
Insulet Corporation
Via
Business Wire
Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference
June 02, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia
June 01, 2022
From
Insulet Corporation
Via
Business Wire
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
May 31, 2022
The deal would have been transformative, but may have limited teamwork in the space.
Via
Investor's Business Daily
Looking Into Insulet's Return On Capital Employed
May 26, 2022
According to Benzinga Pro, during Q1, Insulet (NASDAQ:PODD) earned $27.80 million, a 4.79% increase from the preceding quarter. Insulet's sales decreased to $295.40 million, a 4.0% change since Q4.
Via
Benzinga
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
May 24, 2022
One analyst called the rumored deal "transformative," but says the timing is unfavorable.
Via
Investor's Business Daily
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
May 24, 2022
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company.
Via
InvestorPlace
Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg
May 24, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
May 24, 2022
Good morning, trader! We're jumping into trading on Tuesday with an overview of the biggest pre-market stock movers this morning!
Via
InvestorPlace
Citigroup Maintains Buy Rating for Insulet: Here's What You Need To Know
May 17, 2022
Citigroup has decided to maintain its Buy rating of Insulet (NASDAQ:PODD) and lower its price target from $350.00 to $310.00. Shares of Insulet are trading up 1.23% over the last 24 hours, at $199.34...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
May 17, 2022
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.